Microbiological pesticides in greenhouses – a possible health risk? Source: Eur Respir J 2006; 28: Suppl. 50, 691s Year: 2006
Passive smoking and CVD. Implementing advice on SHS exposure in clinical practice Source: ERS Course 2015 Year: 2015
Current clinical management of smoke inhalation injuries: a reality check Source: Eur Respir J, 52 (6) 1802163; 10.1183/13993003.02163-2018 Year: 2018
Analysis of influence of only one cigarette in smokers concerning some biological risk factors for cardiovascular disease Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006
Effectiveness of different biomarkers in assessing asphalt exposure health effects Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006
Particulate matter personal monitoring can disclose dangerous exposures from environmental tobacco smoke and cooking activities in patients at risk Source: Eur Respir J 2003; 22: Suppl. 45, 303s Year: 2003
A toxicological perspective Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health Year: 2018
Biochemical and immunological changes in asphalt preparing workers Source: Eur Respir J 2004; 24: Suppl. 48, 366s Year: 2004
Clinical aspects of lung injury associated with e-cigarettes or vaping Source: Virtual Congress 2020 – E-cigarette or Vaping, product use Associated Lung Injury (EVALI) Year: 2020
Risk assessment for nurses occupationally exposed to antineoplastic drugs Source: Eur Respir J 2004; 24: Suppl. 48, 637s Year: 2004
Long-lasting exposure to excess risk from environmental tobacco smoke in the hospitality industry for people with cardiovascular and respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 302s Year: 2003
Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries Source: ERJ Open Res, 5 (4) 00182-2019; 10.1183/23120541.00182-2019 Year: 2019
Design and validation of a questionnaire for asbestos exposure for clinical practice Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019
Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials? Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies Year: 2003
Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011
Air pollution and Respiratory health: epidemiological evidences and clinical implications Source: International Congress 2018 – Air pollution and transplantation: near to one's heart and lungs! Year: 2018
Longitudinal assessment of risk factors exposure and development of respiratory symptoms/diseases Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008
Workplace exposure to secondhand tobacco smoke and the risk of asthma Source: Eur Respir J 2005; 26: Suppl. 49, 139s Year: 2005
Noninvasive assessment in the evaluation of occupational lung diseases Source: Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases Year: 2009
Effectiveness of smoking cessation advice for asbestos workers in the UK Source: Eur Respir J 2005; 26: Suppl. 49, 146s Year: 2005